_version_ 1839208089053560833
autor Alfthan, G., Sundvall, J., Raman, L., Kuulasmaa, K., Tolonen, H., for the European Health Examination Survey Pilot Project, Principal investigators contributing to the ehes pilot project hanna tolonen (ehes cc), Gösswald, Kamtsiuris, Trichopoulou, Naska, Giampaoli, Palmieri, Vanuzzo, Ruiz-castell, Al-kerwi, Calleja, Gauci, Malta, Verschuren, S tell, Heldal, Jentoft, Drygas, Kurjata, Avdicova, Mindell
beschreibung Background Reliable data on clinical biomarkers are necessary in order to assess the health risks of populations and especially in assessing long-term trends related to disease incidence. Methods Ten European laboratories participated in a two-phase quality control exercise of total cholesterol (TC) and high-density lipoprotein-cholesterol (HDL-C) analysis. The European Health Examination Survey Reference Laboratory prepared plasma batches for analysis, and provided target values for them. Two criteria were set for the precision and the systematic error (bias). Three plasma samples were analysed in duplicate on separate days (n=12). Results In Round 1, all laboratories met the acceptable criterion (3%) for precision of TC. The mean bias of all laboratories was 0.99% (95% CI 0.03% to 1.95%). Six laboratories measured samples from Round 2. Five laboratories met the goal criterion of 3%; one failed to meet the acceptable criterion of 5%. The mean bias for HDL-C of the three batches of six laboratories was within goal limits (±5% from target) and that of all 10 within acceptable (±10%). The mean bias of all laboratories was 1.1% (95% CI –0.18 to 2.32). In Round 2 four laboratories met the goal criterion and one the acceptable criterion. Conclusion The quality control exercise demonstrated that although the majority of the laboratories met the strict criteria for systematic error for TC and HDL-C, standardisation of methods is still needed to improve the accuracy of biomarker measurements of laboratories engaged in population health surveys. A protocol is recommended for obtaining reliable and comparable biomarker data between countries.
citation_standardnr 6281946
datenlieferant ipn_articles
feed_id 7602
feed_publisher BMJ Publishing Group
feed_publisher_url http://www.bmj.com/
insertion_date 2018-06-13
journaleissn 1470-2738
journalissn 0143-005X
publikationsjahr_anzeige 2018
publikationsjahr_facette 2018
publikationsjahr_intervall 7984:2015-2019
publikationsjahr_sort 2018
publisher BMJ Publishing Group
quelle Journal of Epidemiology and Community Health
relation http://jech.bmj.com/cgi/content/short/72/7/653?rss=1
search_space articles
shingle_author_1 Alfthan, G., Sundvall, J., Raman, L., Kuulasmaa, K., Tolonen, H., for the European Health Examination Survey Pilot Project, Principal investigators contributing to the ehes pilot project hanna tolonen (ehes cc), Gösswald, Kamtsiuris, Trichopoulou, Naska, Giampaoli, Palmieri, Vanuzzo, Ruiz-castell, Al-kerwi, Calleja, Gauci, Malta, Verschuren, S tell, Heldal, Jentoft, Drygas, Kurjata, Avdicova, Mindell
shingle_author_2 Alfthan, G., Sundvall, J., Raman, L., Kuulasmaa, K., Tolonen, H., for the European Health Examination Survey Pilot Project, Principal investigators contributing to the ehes pilot project hanna tolonen (ehes cc), Gösswald, Kamtsiuris, Trichopoulou, Naska, Giampaoli, Palmieri, Vanuzzo, Ruiz-castell, Al-kerwi, Calleja, Gauci, Malta, Verschuren, S tell, Heldal, Jentoft, Drygas, Kurjata, Avdicova, Mindell
shingle_author_3 Alfthan, G., Sundvall, J., Raman, L., Kuulasmaa, K., Tolonen, H., for the European Health Examination Survey Pilot Project, Principal investigators contributing to the ehes pilot project hanna tolonen (ehes cc), Gösswald, Kamtsiuris, Trichopoulou, Naska, Giampaoli, Palmieri, Vanuzzo, Ruiz-castell, Al-kerwi, Calleja, Gauci, Malta, Verschuren, S tell, Heldal, Jentoft, Drygas, Kurjata, Avdicova, Mindell
shingle_author_4 Alfthan, G., Sundvall, J., Raman, L., Kuulasmaa, K., Tolonen, H., for the European Health Examination Survey Pilot Project, Principal investigators contributing to the ehes pilot project hanna tolonen (ehes cc), Gösswald, Kamtsiuris, Trichopoulou, Naska, Giampaoli, Palmieri, Vanuzzo, Ruiz-castell, Al-kerwi, Calleja, Gauci, Malta, Verschuren, S tell, Heldal, Jentoft, Drygas, Kurjata, Avdicova, Mindell
shingle_catch_all_1 Standardisation of laboratories engaged in lipid analyses of population health examination surveys
Background Reliable data on clinical biomarkers are necessary in order to assess the health risks of populations and especially in assessing long-term trends related to disease incidence. Methods Ten European laboratories participated in a two-phase quality control exercise of total cholesterol (TC) and high-density lipoprotein-cholesterol (HDL-C) analysis. The European Health Examination Survey Reference Laboratory prepared plasma batches for analysis, and provided target values for them. Two criteria were set for the precision and the systematic error (bias). Three plasma samples were analysed in duplicate on separate days (n=12). Results In Round 1, all laboratories met the acceptable criterion (3%) for precision of TC. The mean bias of all laboratories was 0.99% (95% CI 0.03% to 1.95%). Six laboratories measured samples from Round 2. Five laboratories met the goal criterion of 3%; one failed to meet the acceptable criterion of 5%. The mean bias for HDL-C of the three batches of six laboratories was within goal limits (±5% from target) and that of all 10 within acceptable (±10%). The mean bias of all laboratories was 1.1% (95% CI –0.18 to 2.32). In Round 2 four laboratories met the goal criterion and one the acceptable criterion. Conclusion The quality control exercise demonstrated that although the majority of the laboratories met the strict criteria for systematic error for TC and HDL-C, standardisation of methods is still needed to improve the accuracy of biomarker measurements of laboratories engaged in population health surveys. A protocol is recommended for obtaining reliable and comparable biomarker data between countries.
Alfthan, G., Sundvall, J., Raman, L., Kuulasmaa, K., Tolonen, H., for the European Health Examination Survey Pilot Project, Principal investigators contributing to the ehes pilot project hanna tolonen (ehes cc), Gösswald, Kamtsiuris, Trichopoulou, Naska, Giampaoli, Palmieri, Vanuzzo, Ruiz-castell, Al-kerwi, Calleja, Gauci, Malta, Verschuren, S tell, Heldal, Jentoft, Drygas, Kurjata, Avdicova, Mindell
BMJ Publishing Group
0143-005X
0143005X
1470-2738
14702738
shingle_catch_all_2 Standardisation of laboratories engaged in lipid analyses of population health examination surveys
Background Reliable data on clinical biomarkers are necessary in order to assess the health risks of populations and especially in assessing long-term trends related to disease incidence. Methods Ten European laboratories participated in a two-phase quality control exercise of total cholesterol (TC) and high-density lipoprotein-cholesterol (HDL-C) analysis. The European Health Examination Survey Reference Laboratory prepared plasma batches for analysis, and provided target values for them. Two criteria were set for the precision and the systematic error (bias). Three plasma samples were analysed in duplicate on separate days (n=12). Results In Round 1, all laboratories met the acceptable criterion (3%) for precision of TC. The mean bias of all laboratories was 0.99% (95% CI 0.03% to 1.95%). Six laboratories measured samples from Round 2. Five laboratories met the goal criterion of 3%; one failed to meet the acceptable criterion of 5%. The mean bias for HDL-C of the three batches of six laboratories was within goal limits (±5% from target) and that of all 10 within acceptable (±10%). The mean bias of all laboratories was 1.1% (95% CI –0.18 to 2.32). In Round 2 four laboratories met the goal criterion and one the acceptable criterion. Conclusion The quality control exercise demonstrated that although the majority of the laboratories met the strict criteria for systematic error for TC and HDL-C, standardisation of methods is still needed to improve the accuracy of biomarker measurements of laboratories engaged in population health surveys. A protocol is recommended for obtaining reliable and comparable biomarker data between countries.
Alfthan, G., Sundvall, J., Raman, L., Kuulasmaa, K., Tolonen, H., for the European Health Examination Survey Pilot Project, Principal investigators contributing to the ehes pilot project hanna tolonen (ehes cc), Gösswald, Kamtsiuris, Trichopoulou, Naska, Giampaoli, Palmieri, Vanuzzo, Ruiz-castell, Al-kerwi, Calleja, Gauci, Malta, Verschuren, S tell, Heldal, Jentoft, Drygas, Kurjata, Avdicova, Mindell
BMJ Publishing Group
0143-005X
0143005X
1470-2738
14702738
shingle_catch_all_3 Standardisation of laboratories engaged in lipid analyses of population health examination surveys
Background Reliable data on clinical biomarkers are necessary in order to assess the health risks of populations and especially in assessing long-term trends related to disease incidence. Methods Ten European laboratories participated in a two-phase quality control exercise of total cholesterol (TC) and high-density lipoprotein-cholesterol (HDL-C) analysis. The European Health Examination Survey Reference Laboratory prepared plasma batches for analysis, and provided target values for them. Two criteria were set for the precision and the systematic error (bias). Three plasma samples were analysed in duplicate on separate days (n=12). Results In Round 1, all laboratories met the acceptable criterion (3%) for precision of TC. The mean bias of all laboratories was 0.99% (95% CI 0.03% to 1.95%). Six laboratories measured samples from Round 2. Five laboratories met the goal criterion of 3%; one failed to meet the acceptable criterion of 5%. The mean bias for HDL-C of the three batches of six laboratories was within goal limits (±5% from target) and that of all 10 within acceptable (±10%). The mean bias of all laboratories was 1.1% (95% CI –0.18 to 2.32). In Round 2 four laboratories met the goal criterion and one the acceptable criterion. Conclusion The quality control exercise demonstrated that although the majority of the laboratories met the strict criteria for systematic error for TC and HDL-C, standardisation of methods is still needed to improve the accuracy of biomarker measurements of laboratories engaged in population health surveys. A protocol is recommended for obtaining reliable and comparable biomarker data between countries.
Alfthan, G., Sundvall, J., Raman, L., Kuulasmaa, K., Tolonen, H., for the European Health Examination Survey Pilot Project, Principal investigators contributing to the ehes pilot project hanna tolonen (ehes cc), Gösswald, Kamtsiuris, Trichopoulou, Naska, Giampaoli, Palmieri, Vanuzzo, Ruiz-castell, Al-kerwi, Calleja, Gauci, Malta, Verschuren, S tell, Heldal, Jentoft, Drygas, Kurjata, Avdicova, Mindell
BMJ Publishing Group
0143-005X
0143005X
1470-2738
14702738
shingle_catch_all_4 Standardisation of laboratories engaged in lipid analyses of population health examination surveys
Background Reliable data on clinical biomarkers are necessary in order to assess the health risks of populations and especially in assessing long-term trends related to disease incidence. Methods Ten European laboratories participated in a two-phase quality control exercise of total cholesterol (TC) and high-density lipoprotein-cholesterol (HDL-C) analysis. The European Health Examination Survey Reference Laboratory prepared plasma batches for analysis, and provided target values for them. Two criteria were set for the precision and the systematic error (bias). Three plasma samples were analysed in duplicate on separate days (n=12). Results In Round 1, all laboratories met the acceptable criterion (3%) for precision of TC. The mean bias of all laboratories was 0.99% (95% CI 0.03% to 1.95%). Six laboratories measured samples from Round 2. Five laboratories met the goal criterion of 3%; one failed to meet the acceptable criterion of 5%. The mean bias for HDL-C of the three batches of six laboratories was within goal limits (±5% from target) and that of all 10 within acceptable (±10%). The mean bias of all laboratories was 1.1% (95% CI –0.18 to 2.32). In Round 2 four laboratories met the goal criterion and one the acceptable criterion. Conclusion The quality control exercise demonstrated that although the majority of the laboratories met the strict criteria for systematic error for TC and HDL-C, standardisation of methods is still needed to improve the accuracy of biomarker measurements of laboratories engaged in population health surveys. A protocol is recommended for obtaining reliable and comparable biomarker data between countries.
Alfthan, G., Sundvall, J., Raman, L., Kuulasmaa, K., Tolonen, H., for the European Health Examination Survey Pilot Project, Principal investigators contributing to the ehes pilot project hanna tolonen (ehes cc), Gösswald, Kamtsiuris, Trichopoulou, Naska, Giampaoli, Palmieri, Vanuzzo, Ruiz-castell, Al-kerwi, Calleja, Gauci, Malta, Verschuren, S tell, Heldal, Jentoft, Drygas, Kurjata, Avdicova, Mindell
BMJ Publishing Group
0143-005X
0143005X
1470-2738
14702738
shingle_title_1 Standardisation of laboratories engaged in lipid analyses of population health examination surveys
shingle_title_2 Standardisation of laboratories engaged in lipid analyses of population health examination surveys
shingle_title_3 Standardisation of laboratories engaged in lipid analyses of population health examination surveys
shingle_title_4 Standardisation of laboratories engaged in lipid analyses of population health examination surveys
timestamp 2025-07-31T23:45:16.897Z
titel Standardisation of laboratories engaged in lipid analyses of population health examination surveys
titel_suche Standardisation of laboratories engaged in lipid analyses of population health examination surveys
topic WW-YZ
uid ipn_articles_6281946